PLAU and prostate disorder: The urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor (uPA/uPAR) axis may play a central role in the aggressive prostate disease through direct and indirect interactions with integrins, growth factors, and endocytosis receptors.